Acciones de aurinia pharmaceuticals inc
12/20/2019 · Find the latest Institutional Holdings data for Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) at Nasdaq.com. Here's Why Aurinia Pharmaceuticals Inc. Jumped 11% in May. May 14, 2018. Here's Why Aurinia Pharmaceuticals Inc. Is Surging Today. Mar 20, 2018. 5 Big Biotech Stocks to Buy Under $10. Feb 22, 2018. Could Aurinia Pharmaceuticals Be a Millionaire-Maker Stock? Jan 19, 2018. A Breakout in Aurinia Pharmaceuticals Inc May Be Imminent. See More 1/30/2019 · Aurinia Pharmaceuticals reported that the drug candidate failed to demonstrate statistical significance in the primary endpoint of drop discomfort, as both voclosporin and Restasis demonstrated low discomfort scores. It's important to note that this objective is not based on safety or efficacy, but rather tolerability. Aurinia Pharmaceuticals Inc, Victoria, British Columbia. 242 likes. We're developing and delivering innovative products to patients living with Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares December 12, 2019 Aurinia Prices US$166.7 Million Public Offering of Common Shares
Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. We are currently developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS).
Aurinia Pharmaceuticals Inc. insider activity by MarketWatch. View the latest news on AUPH company insiders for best stock investing positioning. 12/10/2019 · Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Aurinia Pharmaceuticals Inc. (AUPH). Aurinia is committed to working in areas of high unmet medical need and is currently advancing voclosporin for the treatment of lupus nephritis (LN) and focal segmental glomerulosclerosis (FSGS). Additionally, we are advancing voclosporin ophthalmic solution (VOS) for the treatment of dry eye syndrome (DES). About Voclosporin 12/20/2019 · Find the latest Institutional Holdings data for Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) at Nasdaq.com.
La acción actualmente tiene una calificación promedio de Buy y un precio objetivo promedio de $ 15.65. Las acciones de Aurinia Pharmaceuticals cotizaron a la baja a $ 0.09 durante el mediodía del jueves, llegando a $ 5.64. La acción tenía un volumen de negociación de 600,438 acciones, en comparación con su volumen promedio de 442,446.
Encuentra la cotización más reciente, historial, noticias y otra información vital de Aurinia Pharmaceuticals Inc (AUPH) para ayudarte con tus inversiones e Consulta las últimas cotizaciones de acciones, historial, noticias y otra información vital de Aurinia Pharmaceuticals Inc (AUPH) para ayudarte con tus operaciones 9/29/2019 · Descubre los accionistas directos, los accionistas institucionales y los accionistas de fondos de inversión de Aurinia Pharmaceuticals Inc (AUPH).
Consulta las últimas cotizaciones de acciones, historial, noticias y otra información vital de Aurinia Pharmaceuticals Inc (AUPH) para ayudarte con tus
Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) News Headlines. Oct 11, 2019. Healthcare Stocks That Plunged To New Lows(CTXR,AUPH,AAC). Reaching People, Changing Lives ™. At Aurinia Pharmaceuticals, we're developing innovative products for patients living with debilitating diseases. How We're
Cotizacion de AURINIA PHARMACEUTICALS INC: datos históricos y cotizaciones en tiempo real, gráficos, noticias, análisis, señales de trading, calendario
Aurinia is committed to working in areas of high unmet medical need and is poised to deliver the first approved therapy in the U.S. and Europe for the treatment of lupus nephritis, or LN. The Voclosporin Advantage 12/18/2019 · Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing.
ARCO - Arcos Dorados Holdings Inc. Look up price, volume and historical data for active stocks. SWOT Analysis & Matrix provide insight into strategy,internal & external factors.Buy custom SWOT analysis & SWOT Matrix for $11.Strengths,Weakness Opportunities Threats Click to news headlines for various stocks / companies in the stock market. List of US stocks whose names start with A